Benign biliary strictures refractory to standard bilioplasty
treated using polydoxanone biodegradable biliary stents:
retrospective multicentric data analysis on 107 patients

J 2016

Benign biliary strictures refractory to standard bilioplasty treated using polydoxanone biodegradable biliary stents: retrospective multicentric data analysis on 107 patients

MAURI, G.; C. MICHELOZZI; F. MELCHIORRE; D. PORETTI; V. PEDICINI et al.

Základní údaje

Originální název

Benign biliary strictures refractory to standard bilioplasty treated using polydoxanone biodegradable biliary stents: retrospective multicentric data analysis on 107 patients

Autoři

Vydání

European Radiology, New York, Springer, 2016, 0938-7994

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30000 3. Medical and Health Sciences

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 3.967

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/16:00093917

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

Biliary stricture; Percutaneous transhepatic cholangiography; Percutaneous transhepatic bilioplasty; Bioabsorbable biliary stent

Štítky

EL OK

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 16. 3. 2017 17:44, Soňa Böhmová

Anotace

V originále

To assess mid-term outcome of biodegradable biliary stents (BBSs) to treat benign biliary strictures refractory to standard bilioplasty. Institutional review board approval was obtained and patient consent was waived. 107 patients (61 males, 46 females, mean age 59 +/- 16 years), were treated. Technical success and complications were recorded. Ninety-seven patients (55 males, 42 females, aged 57 +/- 17 years) were considered for follow-up analysis (mean follow-up 23 +/- 12 months). Fisher's exact test and Mann-Whitney U tests were used and a Kaplan-Meier curve was calculated. The procedure was always feasible. In 2/107 cases (2 %), stent migration occurred (technical success 98 %). 4/107 patients (4 %) experienced mild haemobilia. No major complications occurred. In 19/97 patients (18 %), stricture recurrence occurred. In this group, higher rate of subsequent cholangitis (84.2 % vs. 12.8 %, p = 0.001) and biliary stones (26.3 % vs. 2.5 %, p = 0.003) was noted. Estimated mean time to stricture recurrence was 38 months (95 % C.I 34-42 months). Estimated stricture recurrence rate at 1, 2, and 3 years was respectively 7.2 %, 26.4 %, and 29.4 %. Percutaneous placement of a BBS is a feasible and safe strategy to treat benign biliary strictures refractory to standard bilioplasty, with promising results in the mid-term period. aEuro cent Percutaneous placement of a BBS is 100 % feasible. aEuro cent The procedure appears free from major complications, with few minor complications. aEuro cent BBSs offer promising results in the mid-term period. aEuro cent With a BBS, external catheter/drainage can be removed early. aEuro cent BBSs represent a new option in treating benign biliary stenosis.

Citovat

MAURI, G.; C. MICHELOZZI; F. MELCHIORRE; D. PORETTI; V. PEDICINI; M. SALVETTI; E. CRIADO; J.F. FAGES; MA DE GREGORIO; A. LABORDA; L.M. SONFIENZA; G. CORNALBA; L. MONFARDINI; Jiří PÁNEK; Tomáš ANDRAŠINA a M. GIMENEZ. Benign biliary strictures refractory to standard bilioplasty treated using polydoxanone biodegradable biliary stents: retrospective multicentric data analysis on 107 patients. European Radiology. New York: Springer, 2016, roč. 26, č. 11, s. 4057-4063. ISSN 0938-7994. Dostupné z: https://doi.org/10.1007/s00330-016-4278-6.

@article{1375694,
   author = {Mauri, G. and Michelozzi, C. and Melchiorre, F. and Poretti, D. and Pedicini, V. and Salvetti, M. and Criado, E. and Fages, J.F. and De Gregorio, MA and Laborda, A. and Sonfienza, L.M. and Cornalba, G. and Monfardini, L. and Pánek, Jiří and Andrašina, Tomáš and Gimenez, M.},
   article_location = {New York},
   article_number = {11},
   doi = {https://doi.org/10.1007/s00330-016-4278-6},
   keywords = {Biliary stricture; Percutaneous transhepatic cholangiography; Percutaneous transhepatic bilioplasty; Bioabsorbable biliary stent},
   language = {eng},
   issn = {0938-7994},
   journal = {European Radiology},
   title = {Benign biliary strictures refractory to standard bilioplasty treated using polydoxanone biodegradable biliary stents: retrospective multicentric data analysis on 107 patients},
   volume = {26},
   year = {2016}
}

TY  - JOUR
ID  - 1375694
AU  - Mauri, G. - Michelozzi, C. - Melchiorre, F. - Poretti, D. - Pedicini, V. - Salvetti, M. - Criado, E. - Fages, J.F. - De Gregorio, MA - Laborda, A. - Sonfienza, L.M. - Cornalba, G. - Monfardini, L. - Pánek, Jiří - Andrašina, Tomáš - Gimenez, M.
PY  - 2016
TI  - Benign biliary strictures refractory to standard bilioplasty treated using polydoxanone biodegradable biliary stents: retrospective multicentric data analysis on 107 patients
JF  - European Radiology
VL  - 26
IS  - 11
SP  - 4057-4063
EP  - 4057-4063
PB  - Springer
SN  - 09387994
KW  - Biliary stricture
KW  - Percutaneous transhepatic cholangiography
KW  - Percutaneous transhepatic bilioplasty
KW  - Bioabsorbable biliary stent
N2  - To assess mid-term outcome of biodegradable biliary stents (BBSs) to treat benign biliary strictures refractory to standard bilioplasty. Institutional review board approval was obtained and patient consent was waived. 107 patients (61 males, 46 females, mean age 59 +/- 16 years), were treated. Technical success and complications were recorded. Ninety-seven patients (55 males, 42 females, aged 57 +/- 17 years) were considered for follow-up analysis (mean follow-up 23 +/- 12 months). Fisher's exact test and Mann-Whitney U tests were used and a Kaplan-Meier curve was calculated. The procedure was always feasible. In 2/107 cases (2 %), stent migration occurred (technical success 98 %). 4/107 patients (4 %) experienced mild haemobilia. No major complications occurred. In 19/97 patients (18 %), stricture recurrence occurred. In this group, higher rate of subsequent cholangitis (84.2 % vs. 12.8 %, p = 0.001) and biliary stones (26.3 % vs. 2.5 %, p = 0.003) was noted. Estimated mean time to stricture recurrence was 38 months (95 % C.I 34-42 months). Estimated stricture recurrence rate at 1, 2, and 3 years was respectively 7.2 %, 26.4 %, and 29.4 %. Percutaneous placement of a BBS is a feasible and safe strategy to treat benign biliary strictures refractory to standard bilioplasty, with promising results in the mid-term period. aEuro cent Percutaneous placement of a BBS is 100 % feasible. aEuro cent The procedure appears free from major complications, with few minor complications. aEuro cent BBSs offer promising results in the mid-term period. aEuro cent With a BBS, external catheter/drainage can be removed early. aEuro cent BBSs represent a new option in treating benign biliary stenosis.
ER  -

MAURI, G.; C. MICHELOZZI; F. MELCHIORRE; D. PORETTI; V. PEDICINI; M. SALVETTI; E. CRIADO; J.F. FAGES; MA DE GREGORIO; A. LABORDA; L.M. SONFIENZA; G. CORNALBA; L. MONFARDINI; Jiří PÁNEK; Tomáš ANDRAŠINA a M. GIMENEZ. Benign biliary strictures refractory to standard bilioplasty treated using polydoxanone biodegradable biliary stents: retrospective multicentric data analysis on 107 patients. \textit{European Radiology}. New York: Springer, 2016, roč.~26, č.~11, s.~4057-4063. ISSN~0938-7994. Dostupné z: https://doi.org/10.1007/s00330-016-4278-6.

Přehled o publikaci